|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquisition
|
Acquired by Bionomics Limited
|
|
gptkbp:business_model
|
biopharmaceutical development
|
|
gptkbp:capital
|
varies
|
|
gptkbp:ceo
|
Daniel Swisher
|
|
gptkbp:clinical_trial
|
yes
ongoing
publicly traded
published
reported
defined
various stages
|
|
gptkbp:collaborations
|
academic institutions
biopharmaceutical companies
with universities
|
|
gptkbp:drug_approvals
|
pursued
|
|
gptkbp:drug_candidates
|
in development
|
|
gptkbp:drug_discovery
|
innovative approaches
|
|
gptkbp:financials
|
gptkb:venture_capital
|
|
gptkbp:focus
|
oncology
|
|
gptkbp:founded
|
gptkb:2000
|
|
gptkbp:founder
|
Daniel Swisher
|
|
gptkbp:funding
|
secured funding
|
|
gptkbp:has_advisory_board
|
established
|
|
gptkbp:head_of_state
|
active efforts
|
|
gptkbp:headquarters
|
gptkb:San_Francisco,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sunesis Pharmaceuticals
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:initiatives
|
ongoing
|
|
gptkbp:instruction_set
|
diverse
multiple drug candidates
|
|
gptkbp:invention
|
multiple patents granted
|
|
gptkbp:investment
|
active
various venture capital firms
conducted regularly
provided regularly
significant funding rounds
|
|
gptkbp:investment_focus
|
oncology drugs
|
|
gptkbp:is_a_platform_for
|
kinase inhibitors
|
|
gptkbp:leadership
|
experienced management team
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:marketing_strategy
|
focused on oncology
|
|
gptkbp:number_of_employees
|
50-100
|
|
gptkbp:partnership
|
negotiated
|
|
gptkbp:partnerships
|
global pharmaceutical companies
multiple pharmaceutical companies
|
|
gptkbp:products
|
VS-4718
VS-6063
|
|
gptkbp:publications
|
numerous
|
|
gptkbp:regulatory_compliance
|
yes
filed
|
|
gptkbp:research
|
drug development
|
|
gptkbp:research_areas
|
various cancers
|
|
gptkbp:research_focus
|
small molecule therapeutics
|
|
gptkbp:stock_exchange
|
yes
|
|
gptkbp:targets
|
gptkb:Oncology
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:type_of_business
|
headquartered in San Francisco
|
|
gptkbp:website
|
www.sunesis.com
|
|
gptkbp:bfsParent
|
gptkb:Cerdulatinib
|
|
gptkbp:bfsLayer
|
7
|